鼻咽癌放疗后分泌性中耳炎影响因素的Meta分析
作者:
基金项目:

国家自然科学基金(81760184,82060185)。


Factors influencing secretory otitis media after radiotherapy for nasopharyngeal carcinoma:a Meta-analysis
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的 对鼻咽癌(NPC)放疗后分泌性中耳炎(SOM)形成的影响因素进行系统评价。方法 检索英文数据库(Pubmed、Embase、Cochrane library)、中文数据库(中国知网、万方、维普),检索时间为数据库建库至2021年8月15日。按照纳入标准与排除标准检索文献后获取临床研究资料。使用Review Manager 5.4对纳入的研究进行Meta分析。质量评价采用New Castle-Ottawa Scale(NOS)进行评估。使用二分类变量描述性别、腭帆张肌萎缩程度≥30%、咽鼓管受累、肿瘤分期(T1-T2、T3-T4)、放疗剂量≥70Gy以及是否使用调强放射治疗(IMRT)。使用连续变量描述年龄和放疗时间。使用随机效应模型评估纳入的数据。结果 本文共纳入7项病例对照研究(757例患者)。结果显示年龄、性别和是否使用IMRT对放疗后SOM形成的影响上差异无统计学意义(P>0.05)。而腭帆张肌萎缩程度≥30%、咽鼓管受累、肿瘤分期T1-T2、T3-T4、放疗剂量≥70Gy、放疗时间对放疗后SOM形成的影响具有统计学意义(P<0.05)。结论 腭帆张肌萎缩程度≥30%、咽鼓管受累、肿瘤分期(T1-T2、T3-T4)、放疗剂量≥70Gy和放疗时间可能是影响NPC放疗后SOM形成的因素。

    Abstract:

    Objective To evaluate the influencing factors of secretory otitis media (SOM) after radiotherapy for nasopharyngeal carcinoma (NPC) systematically.Methods English databases (Pubmed, Embase, Cochrane library) and Chinese databases (CNKI, Wanfang, Weipu) were searched from the establishment of the database to August 15, 2021. According to the inclusion criteria and exclusion criteria, clinical research data were obtained. Meta-analysis of the involved studies was performed using Review Manager 5.4. The New Castle-Ottawa Scale (NOS) was used for quality evaluation. The binary variables were used to describe gender, staphylinus externus atrophy ≥30%, eustachian tube involvement, tumor stage (T1-T2, T3-T4), radiotherapy dosage ≥70Gy, and whether to use intensity-modulated radiotherapy (IMRT). The continuous variables were used to describe age and radiotherapy duration. The random effect model was used to evaluate the involved data.Results Seven case-control studies (757 patients) were included in this study. The results showed that age (P=0.35), gender (P=0.77) and whether to use IMRT (P=0.76) had no statistically significant differences in the effects of SOM formation after radiotherapy. Staphylinus externus atrophy ≥30% (P=0.01), eustachian tube involvement (P<0.01), tumor stage T1-T2 (P=0.02) and T3-T4 (P=0.02), radiotherapy dosage ≥70 Gy (P<0.01) as well as radiotherapy duration (P<0.01) had statistically significant effects on the formation of SOM after radiotherapy.Conclusion The atrophy degree of staphylinus externus ≥30%, eustachian tube involvement, tumor stage (T1-T2, T3-T4), radiotherapy dosage ≥70 Gy, and radiotherapy duration may be factors influencing the formation of SOM after radiotherapy for NPC.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet,2019,394(10192):64-80.
    [2] Hoffman HT, Karnell LH, Funk GF,et al. The National Cancer Data Base report on cancer of the head and neck[J]. Arch Otolaryngol Head Neck Surg,1998,124(9):951-962.
    [3] Tsang CM, Lui VWY, Bruce JP, et al. Translational genomics of nasopharyngeal cancer[J]. Semin Cancer Biol,2020,61:84-100.
    [4] 付振涛,郭晓雷,张思维,等. 2014年中国鼻咽癌发病与死亡分析[J]. 中华肿瘤杂志, 2018,40(8):566-571.
    [5] Yang Y, Li X, Zhou P, et al. Survival effects of radiotherapy on patients newly diagnosed with distant metastatic nasopharyngeal carcinoma in non-high-incidence areas[J]. Cancer Manag Res,2021,13:8169-8178.
    [6] Honoré HB BS, Bentzen SM, Møller K, et al. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma:individualized risk estimation[J]. Radiother Oncol,2002,65(1):9-16.
    [7] McDowell L, Corry J, Ringash J, et al. Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors[J]. Front Oncol,2020,10:930.
    [8] Yeh SA, Tang Y, Lui CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone[J]. Int J Radiat Oncol Biol Phys, 2005,62(3):672-679.
    [9] Wang SZ, Li J, Miyamoto CT, et al. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique[J]. Radiother Oncol,2009,93(3):530-533.
    [10] Chi FH, Young YH. Inner ear deficits in irradiated nasopharyngeal carcinoma survivors[J]. Laryngoscope,2015,125(11):2565-2571.
    [11] Liang KL, Su MC, Twu CW, et al. Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma[J]. Eur Arch Otorhinolaryngol, 2011,268(2):213-217.
    [12] Wang SZ, Wang WF, Zhang HY, et al. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion[J]. Radiother Oncol,2007,85(3):463-468.
    [13] Sun H, Cao C, Qiu X, et al. Efficacy of balloon dilatation of the eustachian tube in patients with refractory otitis media with effusion after radiotherapy for nasopharyngeal carcinoma[J]. Am J Otolaryngol,2020,41(6):102724.
    [14] Chua MLK, Wee JTS, Hui EP, et al. Nasopharyngeal carcinoma[J]. Lancet,2016,387(10022):1012-1024.
    [15] 周永. 国内鼻咽癌放疗后耳鼻咽喉并发症的现状与思考[J]. 中国耳鼻咽喉颅底外科杂志,2018,24(3):193-196.
    [16] Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions:explanation and elaboration[J]. PLoS Med,2009,6(7):e1000100.
    [17] 王苑,张海琴,李莉,等. 三维放射治疗鼻咽癌并发分泌性中耳炎的临床研究[J]. 中国肿瘤临床与康复,2019,26(9):1077-1080.
    [18] 邓丽芳,李碧玉,吴盖珍,等. 鼻咽癌放疗后并发分泌性中耳炎92例临床分析[J]. 海南医学,2018,29(12):1756-1758.
    [19] 彭有全. 鼻咽癌放疗后并发分泌性中耳炎的特征及相关因素分析[J]. 中国基层医药, 2019,26(8):923-925.
    [20] 张钦华,利锦燕,邹雨荷. 鼻咽癌调强放疗后并发分泌性中耳炎相关因素研究[J]. 黑龙江中医药,2019,48(2):250-251.
    [21] 林浩然,李郁明,杨田福. 鼻咽癌放疗并发分泌性中耳炎的临床病理特征及影响因素分析[J]. 临床医学工程,2020,2707):875-876.
    [22] 车凯军. 鼻咽癌中耳高剂量放疗对分泌性中耳炎发生率的影响[D]. 汕头:汕头大学医学院,2013:1-39.
    [23] Hsin CH, Chen TH, Young YH, et al. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients[J]. Otolaryngol Head Neck Surg,2010,143(5):662-668.
    [24] Poon I, Xia P, Weinberg V, et al. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2007,69(5):1625-1633.
    [25] Moon SH, Cho KH, Lee CG, et al. IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma:Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)[J]. Strahlenther Onkol,2016,192(6):377-385.
    [26] 何光耀,唐军,尧振兴,等. 鼻咽癌放疗后分泌性中耳炎中IL-1β和内毒素的表达与咽鼓管功能障碍的关系[J]. 中国耳鼻咽喉颅底外科杂志, 2018,24(3):202-207.
    [27] 周永,唐安洲. 鼻咽癌放疗后分泌性中耳炎的研究进展[J]. 肿瘤学杂志,2002,8(1):49-51.
    [28] 高艺玲,唐安洲,刘津,等. 鼻咽癌放疗前后腭帆张肌横截面积的改变与分泌性中耳炎的相关性分析[J]. 临床耳鼻咽喉头颈外科杂志,2010,24(16):743-745.
    [29] Young YH. Irradiated ears in nasopharyngeal carcinoma survivors:A review[J]. Laryngoscope,2019,129(3):637-642.
    [30] 唐安洲,曾钢,周永,等. CT扫描对鼻咽癌并发分泌性中耳炎的辅助诊断意义[J]. 临床耳鼻咽喉科杂志,2000,14(8):359-361.
    [31] Kuo CL, Wang MC, Chu CH, et al. New therapeutic strategy for treating otitis media with effusion in postirradiated nasopharyngeal carcinoma patients[J]. J Chin Med Assoc, 2012,75(7):329-334.
    [32] 龚桃根,文忠,柯朝阳. 鼻咽癌放疗后分泌性中耳炎的病因及发病机制[J]. 中华耳科学杂志,2018,16(6):903-906.
    引证文献
引用本文

郭丽青,苗春雨,付衍朋,刘月辉.鼻咽癌放疗后分泌性中耳炎影响因素的Meta分析[J].中国耳鼻咽喉颅底外科杂志,2022,28(6):53-60

复制
分享
文章指标
  • 点击次数:96
  • 下载次数: 211
历史
  • 收稿日期:2021-12-07
  • 在线发布日期: 2023-01-06
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭